Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón
R
R
Estrada
S
S
Ramírez de la Piscina
P
P
Salvador
M
M
Zabaleta
S
S
Enciso
C
C
Delgado
E
E
García-Campos
F
F
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001012:Aorta, Abdominal / Q000473:pathology; D001025:Aortitis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D018810:Magnetic Resonance Angiography; D019804:Mesalamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D013625:Takayasu Arteritis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D019804:Mesalamine; D000069285:Infliximab; D001379:Azathioprine; D008775:Methylprednisolone; D008727:Methotrexate